Aquitaine Science Transfert's new incubator will provide $22,600 of initial funding to help build out nascent deep tech projects.

Novo, Pfizer and Nan Fung helped provide $93.5m for the Stanford immunotherapy spinout as it advances its lead asset towards the clinic.

Novo, Pfizer and Nan Fung helped provide $93.5m for the cancer treatment developer as it advances its lead product candidate towards the clinic.

Existing backer Legend Capital contributed to an eight-figure dollar round for the chemistry services provider having initially invested in 2017.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

BPIfrance’s Large Venture fund and Mubadala Capital added $18m to the medical data research platform's GV-backed series A round.

Existing backer Legend Capital contributed to an eight-figure dollar round for the Tsinghua-backed chemistry services provider.

Advancing research from institutions including Harvard, kidney disease-focused Goldfinch Bio now has its sights on clinical trials.

Sinopec Capital and Meinian Onehealth both invested in the biotech research product maker as it prepares for an initial public offering.

Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.